CORMORANT ASSET MANAGEMENT, LP

Adviser information for CORMORANT ASSET MANAGEMENT, LP last updated from Form ADV on March 30th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 14
Investment Advisory/Research 6
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 14 $4.0B
Non-Discretionary 0 $0
Total 14 $4.0B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 13 $4.0B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other <5 $9.7M
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 57

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-79513
SEC ERA File Number 801-79513
SEC CIK Numbers 1583977
SEC CRD Numbers 167820
Legal Entity Identifier None

Principal Office

200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
United States
Monday - Friday, 9:00AM - 6:00PM
Tel: 857-702-0370, Fax: 617-507-5905

Chief Compliance Officer

NEB OBRADOVIC
GENERAL COUNSEL
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
United States
Tel: 857-702-0386
Fax: 617-507-5905
(Full email address available in API data)

Regulatory Contact

TEDDY WAN
COMP.IANCE ASSOCIATE
200 CLARENDON STREET
52ND FLOOR
BOSTON
MA
United States
Tel: 857-702-0385
Fax: 617-507-5905
(Full email address available in API data)

Industry Affiliates

CORMORANT ASSET MANAGEMENT PUERTO RICO LLC Other investment adviser, including financial planners
CORMORANT GLOBAL HEALTHCARE GP, LLC Sponsor, GP, manager of pooled investment vehicles
CORMORANT PRIVATE HEALTHCARE GP II, LLC Sponsor, GP, manager of pooled investment vehicles
CORMORANT PRIVATE HEALTHCARE GP III, LLC Sponsor, GP, manager of pooled investment vehicles
CORMORANT PRIVATE HEALTHCARE GP IV, LLC Sponsor, GP, manager of pooled investment vehicles
CORMORANT PRIVATE HEALTHCARE GP V, LLC Sponsor, GP, manager of pooled investment vehicles
CORMORANT PRIVATE HEALTHCARE GP, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP Hedge Fund $1,914.8M $1.0M 157
CORMORANT PRIVATE HEALTHCARE FUND I, LP Private Equity Fund $125.4M $5.0M 51
CORMORANT PRIVATE HEALTHCARE FUND II, LP Private Equity Fund $379.9M $5.0M 82
CORMORANT PRIVATE HEALTHCARE FUND III, LP Private Equity Fund $732.8M $5.0M 117
CORMORANT PRIVATE HEALTHCARE FUND IV, LP Private Equity Fund $498.6M $5.0M 94
CORMORANT PRIVATE HEALTHCARE FUND V, LP Private Equity Fund $361.2M $5.0M 40

Control Persons

Name Type Entity Title Since Ownership
CHEN, BIHUA Individual MANAGING MEMBER & CHIEF EXECUTIVE OFFICER 03/2013 > 75%
OBRADOVIC, NEBOJSA Individual CHIEF COMPLIANCE OFFICER & GENERAL COUNSEL 01/2016 < 5%
CORMORANT ASSET MANAGEMENT GP, LLC Domestic Entity GENERAL PARTNER 03/2018 < 5%
CHEN, BIHUA Individual CORMORANT ASSET MANAGEMENT GP, LLC MANAGING MEMBER 03/2014 > 75%
TRIPP, CALEB, JONATHAN Individual CHIEF FINANCIAL OFFICER & CHIEF OPERATING OFFICER 08/2020 < 5%

No. Employees, Historic

2010020192020202120222023202420257 on 5/17/20197 on 1/17/20207 on 3/30/20207 on 11/27/20209 on 3/31/20219 on 11/15/202114 on 3/31/202214 on 10/10/202213 on 3/31/202313 on 11/13/202314 on 3/30/2024

RAUM, Historic

6B3B020192020202120222023202420252141576219 on 5/17/20192141576219 on 1/17/20203318024177 on 3/30/20203318024177 on 11/27/20205438613250 on 3/31/20215438613250 on 11/15/20213392023000 on 3/31/20223392023000 on 10/10/20223117053633 on 3/31/20233117053633 on 11/13/20234022479936 on 3/30/2024

No. Clients, Historic

2010020192020202120222023202420257 on 5/17/20197 on 1/17/20208 on 3/30/20208 on 11/27/202010 on 3/31/202110 on 11/15/202112 on 3/31/202212 on 10/10/202212 on 3/31/202312 on 11/13/202314 on 3/30/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ABIVAX SA SPONSORED ADS 28M 2M Chen Bihua
ALUMIS INC COM 29M 2M Chen Bihua
ARCELLX INC COMMON STOCK 84M 2M Chen Bihua
ARCUTIS BIOTHERAPEUTICS INC COM 23M 3M Chen Bihua
ARRIVENT BIOPHARMA INC COM 10M 515K Chen Bihua
AVIDITY BIOSCIENCES INC COM 17M 425K Chen Bihua
AXSOME THERAPEUTICS INC COM 32M 400K Chen Bihua
BIOHAVEN LTD COM 28M 802K Chen Bihua
BIOMEA FUSION INC COM 16M 4M Chen Bihua
BRIDGEBIO PHARMA INC COM 47M 2M Chen Bihua
CARGO THERAPEUTICS INC COM 19M 1M Chen Bihua
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 15M 2M Chen Bihua
CG ONCOLOGY INC COM 31M 975K Chen Bihua
COMPASS THERAPEUTICS INC COM 2M 2M Chen Bihua
CORBUS PHARMACEUTICALS HLDGS COM NEW 92M 2M Chen Bihua
CRINETICS PHARMACEUTICALS IN COM 60M 1M Chen Bihua
CULLINAN THERAPEUTICS INC COM 20M 1M Chen Bihua
EDGEWISE THERAPEUTICS INC COM 54M 3M Chen Bihua
ENGENE HOLDINGS INC COM 9M 1M Chen Bihua
EYEPOINT PHARMACEUTICALS INC COM NEW 72M 8M Chen Bihua
GH RESEARCH PLC ORDINARY SHARES 7M 593K Chen Bihua
HELIX ACQUISITION CORP II CL A ORD SHS 30M 3M Chen Bihua
IDEAYA BIOSCIENCES INC COM 9M 245K Chen Bihua
IMMUNITYBIO INC COM 8M 1M Chen Bihua
INSMED INC COM PAR $.01 45M 675K Chen Bihua
JANUX THERAPEUTICS INC COM 44M 1M Chen Bihua
KORRO BIO INC COM 9M 266K Chen Bihua
LANTHEUS HLDGS INC COM 6M 75K Chen Bihua
LONGBOARD PHARMACEUTICALS IN COM 75M 3M Chen Bihua
MERSANA THERAPEUTICS INC COM 5M 3M Chen Bihua
MERUS N V COM 50M 840K Chen Bihua
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 373M 8M Chen Bihua
NEUROGENE INC COM 4M 107K Chen Bihua
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES 44M 2M Chen Bihua
PHARVARIS N V COM 28M 1M Chen Bihua
PRAXIS PRECISION MEDICINES I COM NEW 28M 685K Chen Bihua
RAPPORT THERAPEUTICS INC COM 68M 3M Chen Bihua
RAPT THERAPEUTICS INC COM 2M 497K Chen Bihua
RHYTHM PHARMACEUTICALS INC COM 20M 475K Chen Bihua
SAREPTA THERAPEUTICS INC COM 20M 125K Chen Bihua
SIGA TECHNOLOGIES INC COM 4M 500K Chen Bihua
SILENCE THERAPEUTICS PLC ADS 12M 625K Chen Bihua
STOKE THERAPEUTICS INC COM 6M 427K Chen Bihua
TARSUS PHARMACEUTICALS INC COM 14M 500K Chen Bihua
UROGEN PHARMA LTD COM 28M 2M Chen Bihua
VAXCYTE INC COM 83M 1M Chen Bihua
VERVE THERAPEUTICS INC COM 2M 350K Chen Bihua
VYNE THERAPEUTICS INC COM 3M 1M Chen Bihua
Y-MABS THERAPEUTICS INC COM 18M 1M Chen Bihua